Lung Cancer Archives - Page 9 of 9

In the processes of treating most cancers, one of the key pieces of information is the appearance of the tumor under the microscope using a technique called light microscopy. In lung cancer, for example, the appearance of the tumor determines both which chemotherapies are safe and which chemotherapies are effective. In addition, tumor appearance also suggests which patients should be tested for mutations that can be targeted by some of the most effective and safest drugs on the market.

Chapel Hill - Cancer therapies targeting specific molecular subtypes of the disease allow physicians to tailor treatment to a patient’s individual molecular profile. But scientists are finding that in many types of cancer the molecular subtypes are more varied than previously thought and contain further genetic alterations that can affect a patient’s response to therapy.

A team of scientists, including several from UNC Lineberger, has identified predictive genetic biomarkers in pre-clinical models that affect response to therapy for non-small cell lung cancer (NSCLC). The study was done in parallel to an ongoing clinical trial among lung cancer patients at multiple institutions.

UNC scientists report that in early stage, asymptomatic non-small cell lung cancer, early brain recurrences are potentially detectable prior to surgery and recommend that physicians consider including a routine pre-operative staging brain MRI. In addition, patients whose tumors are determined to be higher risk based on the findings at surgery, should consider post-operative MRI to offer early treatment of unrecognized metastasis.

UNC Lineberger hosted the North Carolina Lung Cancer Partnership Advocacy Summit in the N.C. Cancer Hospital on Saturday, August 28. The agenda included workshops in developing key messages, tips for working with the media, improving lung cancer education and raising awareness and funds for lung cancer. Highlighting the event attended by more than 60 people …

Tag: Lung Cancer

UNC study highlights diagnosis of lung cancer subtypes

Molecular subtypes and genetic alterations may determine response to lung cancer therapy

Predictive biomarkers for lung cancer reported in laboratory finding

UNC scientists recommend rethinking brain MRI for early-stage lung cancer patients

UNC Lineberger Hosts North Carolina Lung Cancer Partnership Summit